Background Intermittent preventive treatment of malaria in pregnancy (IPTp) is a comprehensive treatment protocol of anti-malarial drugs administered to pregnant women to prevent malaria, started at the fourth pregnancy month, with at least three doses of sulfadoxine–pyrimethamine (SP), taken as directly observed treatment (DOT) every 30 days at intervals until childbirth, in combination with other preventive measures. This paper introduces feasibility and adoption concepts as implementation research outcomes (IRO), allowing after a defined intervention, to assess the coverage improvement by IPTp for women attending a reference district hospital in Mali. Specifically, the purpose is to evaluate the feasibility of a reminder tool (provider checklist) to enhance pregnant women’s adoption of information about IPTp-SP uptake as immediate and sustained women practices. Methods The implementation strategy used a reminder checklist about malaria knowledge and the recommended preventive tools. Then, the checklist feasibility was assessed during routine practices with the adoption-level about pregnant women’ knowledge. Quantitative data were collected through a questionnaire distributed to a non-probability purposive sampling targeting 200 pregnant women divided into two groups before and after the checklist intervention. In contrast, the qualitative data were based on in-depth face-to-face gynaecologists’ interviews. Results Both the IROs (feasibility and adoption) were satisfactory. The gynaecologists agreed to the use of this checklist during routine practice with a recommendation to generalize it to other health providers. After a gynaecologist visit, a significant increase of the adoption-level about prior knowledge and preventive tools was noticed. A total of 83% of participants were not knowledgeable about malaria disease before checklist use versus 15% after. Similarly, coverage of women’s SP DOT rose from 0 to 59% after introducing the checklist and the IPTp-SP uptake after the visit was highly significant in the second group. The latter reached 95% of pregnant women with 4–8 months’ gestational age, that mostly respected all SP future visits as theoretically scheduled. Conclusions Generalizing such a checklist reminder will improve women’s knowledge about malaria prevention.
Articles you may be interested inHigh-frequency modulation and bandwidth limitations of GaInNAs double-quantum-well lasers Appl. Phys. Lett. 88, 051103 (2006); 10.1063/1.2170430High-frequency electron beam modulation in a diode with an active plasma cathode
High and moderate power Ka-Band (33-40 GHz) Impatt diode amplifiers for use especially in telecommunication systems have been investigated. We point out the means of obtaining optimal conditions (for SOR or DDR diode parameters and operating conditions) for the principal amplifier characteristics: gain-bandwidth product, output power levels, group delay variations, AM-PM conversion rates.The theoretical results achieved, corroborated by the experimental ones, show the excellent behaviour of these Impatt amplifiers operating in telecommunication systems.
Background: Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) is a comprehensive treatment protocol of antimalarial drugs administered to pregnant women to prevent Malaria, started at the fourth pregnancy month, with at least three doses of Sulfadoxine-pyrimethamine (SP), taken as directly observed treatment (DOT) every 30 days as interval until childbirth, in combination with other preventive measures. This paper introduces feasibility and adoption concepts as implementation research outcomes (IRO), allowing, after a defined intervention, to assess the coverage improvement by intermittent preventive malaria treatment for pregnant women attending a reference District hospital in Mali. Specifically, the purpose is to evaluate the feasibility of a reminder tool (provider checklist) to enhance pregnant women's adoption of information about IPTp-SP as immediate and sustained women practices.Methods: The implementation strategy was based on using a reminder checklist about malaria knowledge and the recommended preventive tools. Then, the checklist feasibility was assessed during routine practices with the adoption-level about pregnant women' knowledge. Quantitative data were collected through a questionnaire distributed to a non-probability purposive sampling targeting 200 pregnant women divided into two groups before and after the checklist intervention. In contrast, the qualitative data were based on in-depth face to face gynaecologists interviews. Results: Both the implementation research outcomes (feasibility and adoption) were satisfactory. The gynaecologists agreed of the easy use of this checklist during the routine practice with a recommendation to generalise it to other health providers. After the gynaecologist visit, a significant increase of the adoption-level about the prior knowledge and preventive tools was noticed. A total of 83% of participants were not knowledgeable about malaria disease before checklist use vs 15% after. Similarly, women's coverage to SP DOT increased from 0% to 59% after introducing the checklist and the SP intake after the visit time was highly significative in the second group. The latter reached 95% of the pregnant woman with four and eight months as gestational age, who were the most respectful of all SP future visits as theoretically scheduled.Conclusions: We recommend generalising such a checklist reminder to improve women's knowledge about malaria prevention.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.